{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T06:34:24Z","timestamp":1790836464847,"version":"4.1.0"},"reference-count":81,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T00:00:00Z","timestamp":1751241600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T00:00:00Z","timestamp":1751241600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["30520"],"award-info":[{"award-number":["30520"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Immunol"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1038\/s41590-025-02199-3","type":"journal-article","created":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T05:04:01Z","timestamp":1751259841000},"page":"1352-1366","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["CD4+ T cells license Kupffer cells to reverse CD8+ T cell dysfunction induced by hepatocellular priming"],"prefix":"10.1038","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9815-7887","authenticated-orcid":false,"given":"Valentina","family":"Venzin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9682-4415","authenticated-orcid":false,"given":"Cristian G.","family":"Beccaria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Perucchini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro","family":"Delfino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa B.","family":"Bono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo","family":"Giustini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Moalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Grillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2583-2498","authenticated-orcid":false,"given":"Valeria","family":"Fumagalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Laura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro","family":"Di Lucia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Reinhard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jutta","family":"Petschenka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tana Annmarie","family":"Omokoko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-8273-8004","authenticated-orcid":false,"given":"Anna","family":"Celant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-2506-7121","authenticated-orcid":false,"given":"Sabrina","family":"Ottolini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keigo","family":"Kawashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7606-8368","authenticated-orcid":false,"given":"Micol","family":"Rav\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7521-3092","authenticated-orcid":false,"given":"Marco","family":"De Giovanni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donato","family":"Inverso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9418-1559","authenticated-orcid":false,"given":"Mirela","family":"Kuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick T. F.","family":"Kennedy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3525-7570","authenticated-orcid":false,"given":"Martin","family":"Guilliams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Casorati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Pedica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurilio","family":"Ponzoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0363-1564","authenticated-orcid":false,"given":"U\u011fur","family":"\u015eahin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0502-2527","authenticated-orcid":false,"given":"Nina","family":"Le Bert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2942-0485","authenticated-orcid":false,"given":"Antonio","family":"Bertoletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9839-3484","authenticated-orcid":false,"given":"Fulvia","family":"Vascotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0205-2678","authenticated-orcid":false,"given":"Luca G.","family":"Guidotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9370-2671","authenticated-orcid":false,"given":"Matteo","family":"Iannacone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,30]]},"reference":[{"key":"2199_CR1","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s41577-021-00549-4","volume":"22","author":"M Iannacone","year":"2022","unstructured":"Iannacone, M. & Guidotti, L. G. Immunobiology and pathogenesis of hepatitis B virus infection. Nat. Rev. Immunol. 22, 19\u201332 (2022).","journal-title":"Nat. Rev. Immunol."},{"key":"2199_CR2","doi-asserted-by":"crossref","unstructured":"Kawashima, K., Andreata, F., Beccaria, C. G. & Iannacone, M. Priming and maintenance of adaptive immunity in the liver. Annu. Rev. Immunol. 42, 375\u2013399 (2024).","DOI":"10.1146\/annurev-immunol-090122-041354"},{"key":"2199_CR3","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1016\/j.jhep.2024.05.029","volume":"81","author":"V Venzin","year":"2024","unstructured":"Venzin, V., Beccaria, C. G., Andreata, F., Fumagalli, V. & Iannacone, M. Intrahepatic immunity to hepatitis B virus. J. Hepatol. 81, 911\u2013913 (2024).","journal-title":"J. Hepatol."},{"key":"2199_CR4","doi-asserted-by":"publisher","first-page":"S71","DOI":"10.1016\/j.jhep.2016.01.026","volume":"64","author":"A Bertoletti","year":"2016","unstructured":"Bertoletti, A. & Ferrari, C. Adaptive immunity in HBV infection. J. Hepatol. 64, S71\u2013S83 (2016).","journal-title":"J. Hepatol."},{"key":"2199_CR5","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1038\/s41575-019-0196-9","volume":"16","author":"MK Maini","year":"2019","unstructured":"Maini, M. K. & Burton, A. R. Restoring, releasing or replacing adaptive immunity in chronic hepatitis B. Nat. Rev. Gastroenterol. Hepatol. 16, 662\u2013675 (2019).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"2199_CR6","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1038\/s41586-019-1620-6","volume":"574","author":"AP B\u00e9n\u00e9chet","year":"2019","unstructured":"B\u00e9n\u00e9chet, A. P. et al. Dynamics and genomic landscape of CD8+ T cells undergoing hepatic priming. Nature 574, 200\u2013205 (2019).","journal-title":"Nature"},{"key":"2199_CR7","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.1016\/j.immuni.2021.05.005","volume":"54","author":"G De Simone","year":"2021","unstructured":"De Simone, G. et al. Identification of a Kupffer cell subset capable of reverting the T cell dysfunction induced by hepatocellular priming. Immunity 54, 2089\u20132100 (2021).","journal-title":"Immunity"},{"key":"2199_CR8","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1002\/hep.21378","volume":"44","author":"A Warren","year":"2006","unstructured":"Warren, A. et al. T lymphocytes interact with hepatocytes through fenestrations in murine liver sinusoidal endothelial cells. Hepatology 44, 1182\u20131190 (2006).","journal-title":"Hepatology"},{"key":"2199_CR9","doi-asserted-by":"publisher","first-page":"9652","DOI":"10.1128\/JVI.00867-09","volume":"83","author":"S Asabe","year":"2009","unstructured":"Asabe, S. et al. The size of the viral inoculum contributes to the outcome of hepatitis B virus infection. J. Virol. 83, 9652\u20139662 (2009).","journal-title":"J. Virol."},{"key":"2199_CR10","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1172\/JCI118902","volume":"98","author":"A Penna","year":"1996","unstructured":"Penna, A. et al. Long-lasting memory T cell responses following self-limited acute hepatitis B. J. Clin. Invest. 98, 1185\u20131194 (1996).","journal-title":"J. Clin. Invest."},{"key":"2199_CR11","doi-asserted-by":"publisher","first-page":"3442","DOI":"10.4049\/jimmunol.145.10.3442","volume":"145","author":"C Ferrari","year":"1990","unstructured":"Ferrari, C. et al. Cellular immune response to hepatitis B virus-encoded antigens in acute and chronic hepatitis B virus infection. J. Immunol. 145, 3442\u20133449 (1990).","journal-title":"J. Immunol."},{"key":"2199_CR12","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1002\/hep.510250438","volume":"25","author":"A Penna","year":"1997","unstructured":"Penna, A. et al. Predominant T-helper 1 cytokine profile of hepatitis B virus nucleocapsid-specific T cells in acute self-limited hepatitis B. Hepatology 25, 1022\u20131027 (1997).","journal-title":"Hepatology"},{"key":"2199_CR13","doi-asserted-by":"publisher","first-page":"3358","DOI":"10.1128\/jvi.69.6.3358-3368.1995","volume":"69","author":"MC Jung","year":"1995","unstructured":"Jung, M. C. et al. Activation of a heterogeneous hepatitis B (HB) core and e antigen-specific CD4+ T-cell population during seroconversion to anti-HBe and anti-HBs in hepatitis B virus infection. J. Virol. 69, 3358\u20133368 (1995).","journal-title":"J. Virol."},{"key":"2199_CR14","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1038\/31002","volume":"393","author":"SP Schoenberger","year":"1998","unstructured":"Schoenberger, S. P., Toes, R. E. M., Van Dervoort, E. I. H., Offringa, R. & Melief, C. J. M. T-cell help for cytotoxic T lymphocytes is mediated by CD40\u2013CD40L interactions. Nature 393, 480\u2013483 (1998).","journal-title":"Nature"},{"key":"2199_CR15","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1038\/30996","volume":"393","author":"SRM Bennett","year":"1998","unstructured":"Bennett, S. R. M. et al. Help for cytotoxic-T-cell responses is mediated by CD40 signalling. Nature 393, 478\u2013480 (1998).","journal-title":"Nature"},{"key":"2199_CR16","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1038\/s41577-018-0044-0","volume":"18","author":"J Borst","year":"2018","unstructured":"Borst, J., Ahrends, T., B\u0105ba\u0142a, N., Melief, C. J. M. & Kastenm\u00fcller, W. CD4+ T cell help in cancer immunology and immunotherapy. Nat. Rev. Immunol. 18, 635\u2013647 (2018).","journal-title":"Nat. Rev. Immunol."},{"key":"2199_CR17","doi-asserted-by":"crossref","unstructured":"Mitchison, N. A. & O\u2019Malley, C. Three-cell-type clusters of T cells with antigen-presenting cells best explain the epitope linkage and noncognate requirements of the in vivo cytolytic response. Eur. J. Immunol. 17, 1579\u20131583 (1987).","DOI":"10.1002\/eji.1830171109"},{"key":"2199_CR18","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1038\/30989","volume":"393","author":"JP Ridge","year":"1998","unstructured":"Ridge, J. P., Di Rosa, F. & Matzinger, P. A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell. Nature 393, 474\u2013478 (1998).","journal-title":"Nature"},{"key":"2199_CR19","doi-asserted-by":"crossref","unstructured":"Jobin, K. et al. A distinct priming phase regulates CD8 T cell immunity by orchestrating paracrine IL-2 signals. Science 388, eadq1405 (2025).","DOI":"10.1126\/science.adq1405"},{"key":"2199_CR20","doi-asserted-by":"crossref","unstructured":"Mancini, M., Hadchouel, M., Tiollais, P. & Michel, M. -L. T cells after DNA-based immunization-secreting \u03b3 transgenic mouse model by IFN-expression in a hepatitis B surface antigen regulation of hepatitis B virus mRNA. J. Immunol. 161, 5564\u20135570 (1998).","DOI":"10.4049\/jimmunol.161.10.5564"},{"key":"2199_CR21","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/0022-1759(95)00002-R","volume":"180","author":"V Kouskoff","year":"1995","unstructured":"Kouskoff, V., Signorelli, K., Benoist, C. & Mathis, D. Cassette vectors directing expression of T transgenic mice cell receptor genes in transgenic mice. J. Immunol. Methods 180, 273\u2013280 (1995).","journal-title":"J. Immunol. Methods"},{"key":"2199_CR22","doi-asserted-by":"publisher","first-page":"2969","DOI":"10.1128\/JVI.02111-12","volume":"87","author":"MA Cobleigh","year":"2013","unstructured":"Cobleigh, M. A., Wei, X. & Robek, M. D. A vesicular stomatitis virus-based therapeutic vaccine generates a functional CD8 T cell response to hepatitis B virus in transgenic mice. J. Virol. 87, 2969\u20132973 (2013).","journal-title":"J. Virol."},{"key":"2199_CR23","doi-asserted-by":"publisher","first-page":"e1003490","DOI":"10.1371\/journal.ppat.1003490","volume":"9","author":"M Isogawa","year":"2013","unstructured":"Isogawa, M., Chung, J., Murata, Y., Kakimi, K. & Chisari, F. V. CD40 Activation rescues antiviral CD8+ T cells from PD-1-mediated exhaustion. PLoS Pathog. 9, e1003490 (2013).","journal-title":"PLoS Pathog."},{"key":"2199_CR24","doi-asserted-by":"publisher","first-page":"4078","DOI":"10.1016\/j.cell.2024.05.038","volume":"187","author":"F Andreata","year":"2024","unstructured":"Andreata, F. et al. Therapeutic potential of co-signaling receptor modulation in hepatitis B. Cell 187, 4078\u20134094 (2024).","journal-title":"Cell"},{"key":"2199_CR25","doi-asserted-by":"publisher","first-page":"6158","DOI":"10.1128\/jvi.69.10.6158-6169.1995","volume":"69","author":"LG Guidotti","year":"1995","unstructured":"Guidotti, L. G., Matzke, B., Schaller, H. & Chisari, F. V. High-level hepatitis B virus replication in transgenic mice. J. Virol. 69, 6158\u201369 (1995).","journal-title":"J. Virol."},{"key":"2199_CR26","doi-asserted-by":"crossref","unstructured":"Guidotti, L. G. et al. Viral clearance without destruction of infected cells during acute HBV infection. Science 284, 825\u2013829 (1999).","DOI":"10.1126\/science.284.5415.825"},{"key":"2199_CR27","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/0168-8278(95)80226-6","volume":"22","author":"K Ishak","year":"1995","unstructured":"Ishak, K. et al. Histological grading and staging of chronic hepatitis. J. Hepatol. 22, 696\u2013699 (1995).","journal-title":"J. Hepatol."},{"key":"2199_CR28","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1038\/ni1129","volume":"5","author":"CM Smith","year":"2004","unstructured":"Smith, C. M. et al. Cognate CD4+ T cell licensing of dendritic cells in CD8+ T cell immunity. Nat. Immunol. 5, 1143\u20131148 (2004).","journal-title":"Nat. Immunol."},{"key":"2199_CR29","doi-asserted-by":"publisher","first-page":"5469","DOI":"10.1128\/jvi.68.9.5469-5475.1994","volume":"68","author":"LG Guidotti","year":"1994","unstructured":"Guidotti, L. G., Martinez, V., Lor, Y. -T., Rogler, C. E. & Chisari, F. V. Hepatitis B virus nucleocapsid particles do not cross the hepatocyte nuclear membrane in transgenic mice. J. Virol. 68, 5469\u20135475 (1994).","journal-title":"J. Virol."},{"key":"2199_CR30","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1038\/nature02238","volume":"427","author":"TR Mempel","year":"2004","unstructured":"Mempel, T. R., Henrickson, S. E. & Von Andrian, U. H. T-cell priming by dendritic cells in lymph nodes occurs in three distinct phases. Nature 427, 154\u2013159 (2004).","journal-title":"Nature"},{"key":"2199_CR31","doi-asserted-by":"crossref","unstructured":"Scott, C. L. et al. Bone marrow-derived monocytes give rise to self-renewing and fully differentiated Kupffer cells. Nat. Commun. 7, 10321 (2016).","DOI":"10.1038\/ncomms10321"},{"key":"2199_CR32","doi-asserted-by":"crossref","unstructured":"Celia, M. et al. Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T\u2013T help via APC activation. J. Exp. Med. 184, 747\u2013752 (1996).","DOI":"10.1084\/jem.184.2.747"},{"key":"2199_CR33","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.4049\/jimmunol.1701154","volume":"200","author":"JH DeLong","year":"2018","unstructured":"DeLong, J. H. et al. Cytokine- and TCR-mediated regulation of T cell expression of Ly6C and Sca-1. J. Immunol. 200, 1761\u20131770 (2018).","journal-title":"J. Immunol."},{"key":"2199_CR34","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1146\/annurev-immunol-032414-112134","volume":"33","author":"H Yoshida","year":"2015","unstructured":"Yoshida, H. & Hunter, C. A. The immunobiology of interleukin-27. Annu. Rev. Immunol. 33, 417\u2013443 (2015).","journal-title":"Annu. Rev. Immunol."},{"key":"2199_CR35","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1084\/jem.20190173","volume":"216","author":"Z Huang","year":"2019","unstructured":"Huang, Z. et al. IL-27 promotes the expansion of self-renewing CD8+ T cells in persistent viral infection. J. Exp. Med. 216, 1791\u20131808 (2019).","journal-title":"J. Exp. Med."},{"key":"2199_CR36","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1128\/JVI.01581-07","volume":"82","author":"S Smyk-Pearson","year":"2008","unstructured":"Smyk-Pearson, S. et al. Spontaneous recovery in acute human hepatitis C virus infection: functional T-cell thresholds and relative importance of CD4 help. J. Virol. 82, 1827\u20131837 (2008).","journal-title":"J. Virol."},{"key":"2199_CR37","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1002\/hep.21242","volume":"44","author":"S Urbani","year":"2006","unstructured":"Urbani, S. et al. Outcome of acute hepatitis C is related to virus-specific CD4 function and maturation of antiviral memory CD8 responses. Hepatology 44, 126\u2013139 (2006).","journal-title":"Hepatology"},{"key":"2199_CR38","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1053\/jhep.2000.19324","volume":"32","author":"GJM Webster","year":"2000","unstructured":"Webster, G. J. M. et al. Incubation phase of acute hepatitis B in man: dynamic of cellular immune mechanisms. Hepatology 32, 1117\u20131124 (2000).","journal-title":"Hepatology"},{"key":"2199_CR39","doi-asserted-by":"crossref","unstructured":"Jung, M. -C. et al. Activation of a heterogeneous hepatitis B (HB) core and e antigen-specific CD4+ T-cell population during seroconversion to Anti-HBe and Anti-HBs in hepatitis B virus infection. J. Virol. 69, 3358\u20133368 (1995).","DOI":"10.1128\/jvi.69.6.3358-3368.1995"},{"key":"2199_CR40","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s12865-019-0309-9","volume":"20","author":"Y Dong","year":"2019","unstructured":"Dong, Y. et al. CD4+ T cell exhaustion revealed by high PD-1 and LAG-3 expression and the loss of helper T cell function in chronic hepatitis B. BMC Immunol. 20, 27 (2019).","journal-title":"BMC Immunol."},{"key":"2199_CR41","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1053\/j.gastro.2009.09.052","volume":"138","author":"P Fisicaro","year":"2010","unstructured":"Fisicaro, P. et al. Antiviral intrahepatic T-cell responses can be restored by blocking programmed death-1 pathway in chronic hepatitis B. Gastroenterology 138, 682\u2013693 (2010).","journal-title":"Gastroenterology"},{"key":"2199_CR42","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1016\/j.jhep.2022.05.041","volume":"77","author":"RC Hoogeveen","year":"2022","unstructured":"Hoogeveen, R. C. et al. Hepatitis B virus-specific CD4 T cell responses differentiate functional cure from chronic surface antigen+ infection. J. Hepatol. 77, 1276\u20131286 (2022).","journal-title":"J. Hepatol."},{"key":"2199_CR43","doi-asserted-by":"crossref","unstructured":"Castellino, F. & Germain, R. N. Cooperation between CD4+ and CD8+ T cells: when, where, and how. Ann. Rev. Immunol. 24, 519\u2013540 (2006).","DOI":"10.1146\/annurev.immunol.23.021704.115825"},{"key":"2199_CR44","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1038\/s41586-020-2611-3","volume":"584","author":"ST Ferris","year":"2020","unstructured":"Ferris, S. T. et al. cDC1 prime and are licensed by CD4+ T cells to induce anti-tumour immunity. Nature 584, 624\u2013629 (2020).","journal-title":"Nature"},{"key":"2199_CR45","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1016\/j.immuni.2015.07.020","volume":"43","author":"JL Hor","year":"2015","unstructured":"Hor, J. L. et al. Spatiotemporally distinct interactions with dendritic cell subsets facilitates CD4+ and CD8+ T cell activation to localized viral infection. Immunity 43, 554\u2013565 (2015).","journal-title":"Immunity"},{"key":"2199_CR46","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1016\/j.cell.2015.08.004","volume":"162","author":"S Eickhoff","year":"2015","unstructured":"Eickhoff, S. et al. Robust anti-viral immunity requires multiple distinct T cell-dendritic cell interactions. Cell 162, 1322\u20131337 (2015).","journal-title":"Cell"},{"key":"2199_CR47","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1016\/j.immuni.2019.10.009","volume":"51","author":"R Zander","year":"2019","unstructured":"Zander, R. et al. CD4+ T cell help is required for the formation of a cytolytic CD8+ T cell subset that protects against chronic infection and cancer. Immunity 51, 1028\u20131042 (2019).","journal-title":"Immunity"},{"key":"2199_CR48","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1016\/j.immuni.2017.10.009","volume":"47","author":"T Ahrends","year":"2017","unstructured":"Ahrends, T. et al. CD4+ T cell help confers a cytotoxic T cell effector program including coinhibitory receptor downregulation and increased tissue invasiveness. Immunity 47, 848\u2013861 (2017).","journal-title":"Immunity"},{"key":"2199_CR49","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1038\/s41591-023-02345-0","volume":"29","author":"A Magen","year":"2023","unstructured":"Magen, A. et al. Intratumoral dendritic cell\u2013CD4+ T helper cell niches enable CD8+ T cell differentiation following PD-1 blockade in hepatocellular carcinoma. Nat. Med. 29, 1389\u20131399 (2023).","journal-title":"Nat. Med."},{"key":"2199_CR50","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1016\/j.ccell.2024.05.025","volume":"42","author":"G Espinosa-Carrasco","year":"2024","unstructured":"Espinosa-Carrasco, G. et al. Intratumoral immune triads are required for immunotherapy-mediated elimination of solid tumors. Cancer Cell 42, 1202\u20131216 (2024).","journal-title":"Cancer Cell"},{"key":"2199_CR51","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.cell.2021.12.018","volume":"185","author":"M Guilliams","year":"2022","unstructured":"Guilliams, M. et al. Spatial proteogenomics reveals distinct and evolutionarily conserved hepatic macrophage niches. Cell 185, 379\u2013396 (2022).","journal-title":"Cell"},{"key":"2199_CR52","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1016\/j.immuni.2019.08.017","volume":"51","author":"J Bonnardel","year":"2019","unstructured":"Bonnardel, J. et al. Stellate cells, hepatocytes, and endothelial cells imprint the Kupffer cell identity on monocytes colonizing the liver macrophage niche. Immunity 51, 638\u2013654 (2019).","journal-title":"Immunity"},{"key":"2199_CR53","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1111\/imcb.12559","volume":"100","author":"K English","year":"2022","unstructured":"English, K. et al. The liver contains distinct interconnected networks of CX3CR1+ macrophages, XCR1+ type 1 and CD301a+ type 2 conventional dendritic cells embedded within portal tracts. Immunol. Cell Biol. 100, 394\u2013408 (2022).","journal-title":"Immunol. Cell Biol."},{"key":"2199_CR54","doi-asserted-by":"publisher","first-page":"2351","DOI":"10.1126\/sciimmunol.aba2351","volume":"5","author":"X Ficht","year":"2020","unstructured":"Ficht, X. & Iannacone, M. Immune surveillance of the liver by T cells. Sci. Immunol 5, eaba2351 (2020).","journal-title":"Sci. Immunol"},{"key":"2199_CR55","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.jhep.2010.10.005","volume":"54","author":"IN Crispe","year":"2011","unstructured":"Crispe, I. N. Liver antigen-presenting cells. J. Hepatol. 54, 357\u2013365 (2011).","journal-title":"J. Hepatol."},{"key":"2199_CR56","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1038\/nri.2017.11","volume":"17","author":"O Krenkel","year":"2017","unstructured":"Krenkel, O. & Tacke, F. Liver macrophages in tissue homeostasis and disease. Nat. Rev. Immunol. 17, 306\u2013321 (2017).","journal-title":"Nat. Rev. Immunol."},{"key":"2199_CR57","doi-asserted-by":"crossref","unstructured":"English, K. et al. A hepatic network of dendritic cells mediates CD4+ T cell help outside lymphoid organs. Nat. Commun. 15, 1261 (2024).","DOI":"10.1038\/s41467-024-45612-5"},{"key":"2199_CR58","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1146\/annurev.immunol.22.012703.104758","volume":"25","author":"RA Kastelein","year":"2007","unstructured":"Kastelein, R. A., Hunter, C. A. & Cua, D. J. Discovery and biology of IL-23 and IL-27: related but functionally distinct regulators of inflammation. Annu. Rev. Immunol. 25, 221\u2013242 (2007).","journal-title":"Annu. Rev. Immunol."},{"key":"2199_CR59","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.molmed.2012.12.002","volume":"19","author":"G Murugaiyan","year":"2013","unstructured":"Murugaiyan, G. & Saha, B. IL-27 in tumor immunity and immunotherapy. Trends Mol. Med. 19, 108\u2013116 (2013).","journal-title":"Trends Mol. Med."},{"key":"2199_CR60","doi-asserted-by":"crossref","unstructured":"Chudnovskiy, A. et al. Proximity-dependent labeling identifies dendritic cells that drive the tumor-specific CD4+ T cell response. Sci. Immunol. 9, eadq8843 (2024).","DOI":"10.1126\/sciimmunol.adq8843"},{"key":"2199_CR61","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1038\/s41586-024-07213-6","volume":"628","author":"E Martin","year":"2024","unstructured":"Martin, E. et al. Role of IL-27 in Epstein\u2013Barr virus infection revealed by IL-27RA deficiency. Nature 628, 620\u2013629 (2024).","journal-title":"Nature"},{"key":"2199_CR62","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-024-08510-w","author":"B Br\u00e9art","year":"2025","unstructured":"Br\u00e9art, B. et al. IL-27 elicits a cytotoxic CD8+ T cell program to enforce tumour control. Nature https:\/\/doi.org\/10.1038\/s41586-024-08510-w (2025).","journal-title":"Nature"},{"key":"2199_CR63","doi-asserted-by":"publisher","first-page":"e98745","DOI":"10.1172\/jci.insight.98745","volume":"3","author":"J Zhu","year":"2018","unstructured":"Zhu, J. et al. IL-27 gene therapy induces depletion of Tregs and enhances the efficacy of cancer immunotherapy. JCI Insight 3, e98745 (2018).","journal-title":"JCI Insight"},{"key":"2199_CR64","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1111\/cas.12731","volume":"106","author":"T Yoshimoto","year":"2015","unstructured":"Yoshimoto, T. et al. Potential clinical application of interleukin-27 as an antitumor agent. Cancer Sci. 106, 1103\u20131110 (2015).","journal-title":"Cancer Sci."},{"key":"2199_CR65","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/s41586-020-2537-9","volume":"585","author":"U Sahin","year":"2020","unstructured":"Sahin, U. et al. An RNA vaccine drives immunity in checkpoint-inhibitor-treated melanoma. Nature 585, 107\u2013112 (2020).","journal-title":"Nature"},{"key":"2199_CR66","doi-asserted-by":"crossref","unstructured":"Paret, C. et al. CXorf61 is a target for T cell based immunotherapy of triple-negative breast cancer. Oncotarget 6, 25356\u201325367 (2015).","DOI":"10.18632\/oncotarget.4516"},{"key":"2199_CR67","doi-asserted-by":"publisher","first-page":"4009","DOI":"10.1182\/blood-2006-04-015024","volume":"108","author":"S Holtkamp","year":"2006","unstructured":"Holtkamp, S. et al. Modification of antigen-encoding RNA increases stability, translational efficacy, and T-cell stimulatory capacity of dendritic cells. Blood 108, 4009\u20134017 (2006).","journal-title":"Blood"},{"key":"2199_CR68","doi-asserted-by":"publisher","first-page":"1553478","DOI":"10.1080\/2162402X.2018.1553478","volume":"8","author":"M Vormehr","year":"2019","unstructured":"Vormehr, M. et al. A non-functional neoepitope specific CD8+ T-cell response induced by tumor derived antigen exposure in vivo. Oncoimmunology 8, 1553478 (2019).","journal-title":"Oncoimmunology"},{"key":"2199_CR69","doi-asserted-by":"crossref","unstructured":"Reeves, J. P., Reeves, P. A. & Chin, L. T. Survival surgery: removal of the spleen or thymus. Curr. Protoc. Immunol. 2, 10 (1992).","DOI":"10.1002\/0471142735.im0110s02"},{"key":"2199_CR70","doi-asserted-by":"crossref","unstructured":"Sitia, G. et al. Kupffer cells hasten resolution of liver immunopathology in mouse models of viral hepatitis. PLoS Pathog. 7, e1002061 (2011).","DOI":"10.1371\/journal.ppat.1002061"},{"key":"2199_CR71","doi-asserted-by":"crossref","unstructured":"Andreata, F. et al. Isolation of mouse Kupffer cells for phenotypic and functional studies. STAR Protoc. 2, 100831 (2021).","DOI":"10.1016\/j.xpro.2021.100831"},{"key":"2199_CR72","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1093\/bioinformatics\/btw777","volume":"33","author":"DJ McCarthy","year":"2017","unstructured":"McCarthy, D. J., Campbell, K. R., Lun, A. T. L. & Wills, Q. F. Scater: pre-processing, quality control, normalization and visualization of single-cell RNA-seq data in R. Bioinformatics 33, 1179\u20131186 (2017).","journal-title":"Bioinformatics"},{"key":"2199_CR73","doi-asserted-by":"publisher","first-page":"979","DOI":"10.12688\/f1000research.73600.1","volume":"10","author":"PL Germain","year":"2021","unstructured":"Germain, P. L., Lun, A., Macnair, W. & Robinson, M. D. Doublet identification in single-cell sequencing data using scDblFinder. F1000Res 10, 979 (2021).","journal-title":"F1000Res"},{"key":"2199_CR74","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1038\/s41590-018-0276-y","volume":"20","author":"D Aran","year":"2019","unstructured":"Aran, D. et al. Reference-based analysis of lung single-cell sequencing reveals a transitional profibrotic macrophage. Nat. Immunol. 20, 163\u2013172 (2019).","journal-title":"Nat. Immunol."},{"key":"2199_CR75","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1101\/gr.240093.118","volume":"29","author":"BA Benayoun","year":"2019","unstructured":"Benayoun, B. A. et al. Remodeling of epigenome and transcriptome landscapes with aging in mice reveals widespread induction of inflammatory responses. Genome Res. 29, 697\u2013709 (2019).","journal-title":"Genome Res."},{"key":"2199_CR76","doi-asserted-by":"publisher","first-page":"3573","DOI":"10.1016\/j.cell.2021.04.048","volume":"184","author":"Y Hao","year":"2021","unstructured":"Hao, Y. et al. Integrated analysis of multimodal single-cell data. Cell 184, 3573\u20133587 (2021).","journal-title":"Cell"},{"key":"2199_CR77","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1038\/s41590-020-00836-7","volume":"22","author":"E Kiner","year":"2021","unstructured":"Kiner, E. et al. Gut CD4+ T cell phenotypes are a continuum molded by microbes, not by TH archetypes. Nat. Immunol. 22, 216\u2013228 (2021).","journal-title":"Nat. Immunol."},{"key":"2199_CR78","unstructured":"Marsh, S. scCustomize: custom visualizations & functions for streamlined analyses of single cell sequencing. R package version 2.1.2. https:\/\/samuel-marsh.github.io\/scCustomize\/ (2024)."},{"key":"2199_CR79","doi-asserted-by":"publisher","first-page":"2847","DOI":"10.1093\/bioinformatics\/btw313","volume":"32","author":"Z Gu","year":"2016","unstructured":"Gu, Z., Eils, R. & Schlesner, M. Complex heatmaps reveal patterns and correlations in multidimensional genomic data. Bioinformatics 32, 2847\u20132849 (2016).","journal-title":"Bioinformatics"},{"key":"2199_CR80","doi-asserted-by":"publisher","first-page":"962\u2013970","DOI":"10.1038\/nbt.4231","volume":"36","author":"KB Halpern","year":"2018","unstructured":"Halpern, K. B. et al. Paired-cell sequencing enables spatial gene expression mapping of liver endothelial cells. Nat. Biotechnol. 36, 962\u2013970 (2018).","journal-title":"Nat. Biotechnol."},{"key":"2199_CR81","doi-asserted-by":"publisher","first-page":"10986","DOI":"10.1128\/JVI.01124-08","volume":"82","author":"AT Tan","year":"2008","unstructured":"Tan, A. T. et al. Host ethnicity and virus genotype shape the hepatitis B virus-specific T-cell repertoire. J. Virol. 82, 10986\u201310997 (2008).","journal-title":"J. Virol."}],"container-title":["Nature Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41590-025-02199-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41590-025-02199-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41590-025-02199-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T22:39:13Z","timestamp":1757198353000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41590-025-02199-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,30]]},"references-count":81,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["2199"],"URL":"https:\/\/doi.org\/10.1038\/s41590-025-02199-3","relation":{},"ISSN":["1529-2908","1529-2916"],"issn-type":[{"value":"1529-2908","type":"print"},{"value":"1529-2916","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,30]]},"assertion":[{"value":"6 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"K.R. and T.A.O. are stock owners, and employees at BioNTech. U.S. is stock owner and management board member at BioNTech. P.T.F.K. has acted as a consultant\/advisor for Aligos, Assembly Biosciences, Gilead Sciences, GlaxoSmithKline and Bluejay and received educational grants from Aligos, Gilead Sciences and Vir Biotechnology. N.L.B. and A.B. are the founders and hold stocks of T Cell Diagnostics, a biotech company developing T cell tests for viral infection. A.B. is the cofounder of LION TCR, a company developing T cell therapy against viral-related cancers. A.B. consulted and served on the advisory boards of Brii Biosciences, Assembly Biosciences and Gilead Sciences. L.G.G. participated in boards, advisory boards and consultantships for Genenta Science, Epsilen Bio, Gilead Sciences, Antios Therapeutics, Aligos Therapeutics, Medicxi, Chroma Medicine and Ananda Immunotherapies. M.I. participates in advisory boards\/consultantships or receives funding from Gilead Sciences, GentiBio, BlueJay Therapeutics, BioNTech, Excision BioTherapeutics, Moderna, GSK and Curie.Bio. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}